Nicox to co-promote latanoprostene bunod with Bausch + Lomb in U.S.

Nicox announced its decision to exercise the option to co-promote latanoprostene bunod with Bausch + Lomb in the U.S., according to a company press release.Latanoprostene bunod, a nitric oxide-donating prostaglandin F2-alpha analog, was licensed to Nicox by Bausch + Lomb in 2010. The two companies will begin negotiations of a co-promotion agreement to be signed at a later time, according to the release.

Full Story →